Evidence map›Paper›PMID 38243330›Full record

ArticleDiagnostic pathology2024

Translating prognostic quantification of c-MYC and BCL2 from tissue microarrays to whole slide images in diffuse large B-cell lymphoma using deep learning.

Thomas E Tavolara, M Khalid Khan Niazi, Andrew L Feldman, David L Jaye, Christopher Flowers, Lee A D Cooper, Metin N Gurcan

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Thomas E TavolaraCenter for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA. tavolara.thomas@mayo.edu.
M Khalid Khan NiaziCenter for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
David L JayeDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Christopher FlowersDepartment of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lee A D CooperDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Metin N GurcanCenter for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Wake Forest University · USEmory University · USMayo Clinic in Arizona · USNorthwestern University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
Predicting tuberculosis outcomes using genotypic and biomarker signaturesR01HL145411 · NHLBI · TUFTS UNIVERSITY BOSTON · PI BEAMER, GILLIAN L · 2019 to 2023
$3.4M
Informatics Tools for Quantitative Digital Pathology Profiling and Integrated Prognostic ModelingU01CA220401 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI COOPER, LEE, FLOWERS, CHRISTOPHER R · 2018 to 2021
$1.3M
NCATS NIH HHS UL1 TR001420NCI NIH HHS U01 CA195568NCI NIH HHS U01 CA220401NHLBI NIH HHS R01 HL145411
6 · The paper itself

Abstract

backgroundc-MYC and BCL2 positivity are important prognostic factors for diffuse large B-cell lymphoma. However, manual quantification is subject to significant intra- and inter-observer variability. We developed an automated method for quantification in whole-slide images of tissue sections where manual quantification requires evaluating large areas of tissue with possibly heterogeneous staining. We train this method using annotations of tumor positivity in smaller tissue microarray cores where expression and staining are more homogeneous and then translate this model to whole-slide images.

methodsOur method applies a technique called attention-based multiple instance learning to regress the proportion of c-MYC-positive and BCL2-positive tumor cells from pathologist-scored tissue microarray cores. This technique does not require annotation of individual cell nuclei and is trained instead on core-level annotations of percent tumor positivity. We translate this model to scoring of whole-slide images by tessellating the slide into smaller core-sized tissue regions and calculating an aggregate score. Our method was trained on a public tissue microarray dataset from Stanford and applied to whole-slide images from a geographically diverse multi-center cohort produced by the Lymphoma Epidemiology of Outcomes study.

resultsIn tissue microarrays, the automated method had Pearson correlations of 0.843 and 0.919 with pathologist scores for c-MYC and BCL2, respectively. When utilizing standard clinical thresholds, the sensitivity/specificity of our method was 0.743 / 0.963 for c-MYC and 0.938 / 0.951 for BCL2. For double-expressors, sensitivity and specificity were 0.720 and 0.974. When translated to the external WSI dataset scored by two pathologists, Pearson correlation was 0.753 & 0.883 for c-MYC and 0.749 & 0.765 for BCL2, and sensitivity/specificity was 0.857/0.991 & 0.706/0.930 for c-MYC, 0.856/0.719 & 0.855/0.690 for BCL2, and 0.890/1.00 & 0.598/0.952 for double-expressors. Survival analysis demonstrates that for progression-free survival, model-predicted TMA scores significantly stratify double-expressors and non double-expressors (p = 0.0345), whereas pathologist scores do not (p = 0.128).

conclusionsWe conclude that proportion of positive stains can be regressed using attention-based multiple instance learning, that these models generalize well to whole slide images, and that our models can provide non-inferior stratification of progression-free survival outcomes.

Indexed as

Deep LearningLymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsHumansPrognosisProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycBCL2 protein, humanProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycBCL2c-MYCDeep learningDiffuse large B-cell LymphomaImmunohistochemistryMultiple instance learningTissue microarraysWhole slide images

Identifiers

PMID38243330
PMCPMC10797911
OpenAlexW4391027739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.